- DrugWarRant.com, the longest running single-issue blog devoted to drug policy
Join us on Pete's couch.
Send comments, tips,
and suggestions to: Inflammation and mitochondrial stress were reduced after psilocybin therapy in Parkinson's disease patients: October 21, 2026 -- Markers of systemic…
LSD reconfigures cortical dynamics through faster brain rhythms and increased fractal dimension: 21-Oct-2026 -- After being the subject of extensive…
Naloxone may not be a major reason opioid overdose deaths have fallen: 21-Oct-2026 – PROVIDENCE, R.I. [Brown University] — Increased…
Psilocybin treatments are being tested for treating co-occurring cocaine use disorder and major depression: 21-Oct-2026 – A team of UTHealth…
Monthly Archives: July 2026
ONDCP shields Big Pharma from competition
The U.S. pharmaceutical industry is enormous. A recent analysis placed its 2025 market value at roughly $520 billion, making it the world’s largest national drug market. Government protection of the industry is achieved in part through enforcement of Schedule I … Continue reading
Posted in Servetus
7 Comments
Mindfulness-oriented recovery enhancement in opioid use disorder: 28-Oct-2026 -- Mindfulness-Oriented Recovery Enhancement (MORE), a behavioral therapy used alongside medication treatment,…